JC Ansquer, C Foucher, P Aubonnet, K Le … - Current pharmaceutical design, 2009 - ingentaconnect.com Abstract: Fibrates are widely prescribed lipid-lowering drug in the treatment of
dyslipidemia. Their main clinical effects, mediated by peroxisome proliferative
activated receptor (PPAR) alpha activation, are a moderate reduction in ... Cited by 7 - Related articles - All 3 versions